Memory transmission in small groups and large networks: An empirical study.

Psychon Bull Rev

Department of Psychology, Princeton University, Princeton, NJ, USA.

Published: April 2022

When people try to remember information in a group, they often recall less than if they were recalling alone. This finding is called collaborative inhibition, and has been studied primarily in small groups because of the difficulty of bringing large groups into the laboratory. To study the dynamics of collaborative inhibition in large groups (Luhmann & Rajaram, Psychological Science, 26, 1909-1917, 2015) constructed an agent-based model that extrapolated from previous laboratory experiments with small groups. The model predicts that collaborative inhibition should increase with group size. Here, we evaluate this model by recruiting a large number of participants using crowdsourcing, allowing us to replace the artificial agents in the model with people to study collaborative memory at larger scales. Our empirical results did not match the model predictions: there was no evidence for an increase in collaborative inhibition with group size, despite substantial power to detect such an effect. These findings motivate further empirical work to elucidate the mechanisms of collaborative memory.

Download full-text PDF

Source
http://dx.doi.org/10.3758/s13423-021-02021-9DOI Listing

Publication Analysis

Top Keywords

collaborative inhibition
16
small groups
12
large groups
8
group size
8
collaborative memory
8
collaborative
6
groups
5
model
5
memory transmission
4
transmission small
4

Similar Publications

Background: Tau proteins aggregate in a number of neurodegenerative disorders known as tauopathies. Various studies have highlighted the role of microtubule-binding domains in the intracellular aggregation of Tau protein.

Method: Using a library of synthetic VHHs humanized in collaboration with Hybrigenics, we have developed a number of anti-tau VHHs.

View Article and Find Full Text PDF

Numerous diseases have been connected to protein arginine methylations mediated by protein arginine methyltransferase 5 (PRMT5). Clinical investigations of the PRMT5-specific inhibitor GSK3326595 are currently being conducted, and the results are promising for preventing cancers. However, the detailed mechanism of PRMT5 promoting colorectal cancer (CRC) malignant progression remains unclear.

View Article and Find Full Text PDF

Arachidonic acid synergizes with aspirin preventing myocardial ischemia-reperfusion injury and mitigates bleeding risk.

Cardiovasc Res

January 2025

State Key Laboratory of Cardiovascular Disease, Clinical Pharmacology Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.

Aims: The therapeutic efficacy of coronary revascularization is compromised by myocardial ischemia-reperfusion (MI/R) injury. Higher levels of circulating arachidonic acid (AA) are reportedly associated with lower risk of cardiovascular disease. The cyclooxygenase (COX) pathway metabolizes AA into prostaglandins (PGs) and the platelet-activating thromboxane A2 (TXA2), which is inhibited by aspirin.

View Article and Find Full Text PDF

Megastigmane glycoside and phenol glycosides from the bark of Croizat.

Nat Prod Res

January 2025

Guangxi Key Laboratory of Sericulture Ecology and Applied Intelligent Technology, Guangxi Collaborative Innovation Center of Modern Sericulture and Silk, Hechi University, Hechi, Guangxi, China.

A new megastigmane glycoside, conspurcoside A (), two new phenol glycosides, conspurcosides B () and C (), along with twelve known compounds (-) were isolated from the bark of Croizat. The structures of these compounds were identified through analysis of spectroscopic data, including 1D and 2D NMR, HRESIMS, and ECD methods. Compounds (-, -) were tested for inhibition of NO production in lipopolysaccharide (LPS)-induced RAW 264.

View Article and Find Full Text PDF

Morphological Features Influence the Drug Loading and Delivery Efficacy of Photoactivatable Gold Nanocarriers for Antitumor Photo/Chemotherapy.

ACS Appl Mater Interfaces

January 2025

Institute of Optical Functional Materials for Biomedical Imaging, School of Chemistry and Pharmaceutical Engineering, Shandong First Medical University & Shandong Academy of Medical Science, Taian, Shandong 271016, PR China.

Photoactivatable gold nanocarriers are transforming antitumor therapies by leveraging their distinctive physicochemical properties, enabling targeted drug delivery and enhanced therapeutic efficacy in cancer treatment. This study systematically investigates how surface topography and morphology of gold nanocarriers influence drug loading capacity, light-to-heat conversion efficiency, and overall therapeutic performance in photo/chemotherapy. We synthesized four distinct morphologies of gold nanoparticles: porous gold nanocups (PAuNCs), porous gold nanospheres (PAuNSs), solid gold nanocups (SAuNCs), and solid gold nanospheres (SAuNSs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!